98%
921
2 minutes
20
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.cllc.2024.08.013 | DOI Listing |
Clin Orthop Relat Res
September 2025
Department of Neurosurgery, Leiden University Medical Centre, Leiden, The Netherlands.
Background: Lumbar spinal stenosis (LSS) is common in adults with achondroplasia and predisposes individuals to neurogenic claudication. It remains unverified whether the severity of stenosis in patients with achondroplasia is associated with clinical outcomes. Similarly, the role of sagittal balance parameters in clinical outcomes has not been determined.
View Article and Find Full Text PDFClin Orthop Relat Res
September 2025
Leni & Peter W. May Department of Orthopaedic Surgery, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
Background: Peripheral nerve injury commonly results in pain and long-term disability for patients. Recovery after in-continuity stretch or crush injury remains inherently unpredictable. However, surgical intervention yields the most favorable outcomes when performed shortly after injury.
View Article and Find Full Text PDFJ Robot Surg
September 2025
ORSI Academy, Melle, Belgium.
This Letter to the Editor responds to the recent publication by Patel et al. (J Robot Surg. Jul 11;19(1):370, 2025), which outlines a framework and recommendations for telesurgery.
View Article and Find Full Text PDFInt J Surg
September 2025
Institute of Human Genetics, Jena University Hospital, Jena, Germany.
Blood Cell Ther
August 2025
Department of Clinical Hematology and Medical Oncology, Postgraduate Institute Of Medical Education And Research (PGIMER), Chandigarh, India.
Background: Bone marrow (BM) Measurable Residual Disease (MRD) assessments underestimate disease burden in multiple myeloma, as focal lesions can exist outside the marrow. Functional imaging, like positron emission tomography-computed tomography (PET-CT), offers valuable insights into residual disease beyond the marrow. Combining marrow flow cytometry (FCM) with PET-CT for a composite MRD (cMRD) assessment before and after autologous stem cell transplant (ASCT) is expected to provide prognostic information, particularly in settings where patients receive extended duration of anti-myeloma therapy prior to ASCT.
View Article and Find Full Text PDF